In this episode, Dr. Robert Popovian and Ben Blanc are joined by Kate Hudson, Associate Vice President and Counsel for Government Relations and Public Policy at the Association of American Universities, to dissect the complex issue of march-in rights. They delve into how this regulation negatively influences the partnership between public research and private sector investment, which is crucial for supporting biopharmaceutical innovation from university labs to a patient’s bedside. The episode reveals march-in rights' potential risks and benefits, especially how the policy might impact innovation and patient access to future therapies.

Among the highlights in this episode:

02:25: Researchers found that 75% of all Food and Drug Administration-approved drugs between January 2008 and December 2017 were funded and researched by private companies, with only 19% of the approved drugs having origins in publicly supported research and development, and 6% originating in companies that were spun from publicly supported research programs

03:48: Kate shares her professional journey and current role at the Association of American Universities

06:06: Kate explains the concept of march-in rights under the Bayh-Dole Act, detailing its purpose, application, and implications for intellectual property generated from federally funded research

09:52: Dr. Popovian describes his involvement with University Pharmco and its mission to promote research commercialization, emphasizing the potential impact of march-in rights on such initiatives

12:19: Kate addresses why the debate around march-in rights is crucial from a patient's perspective, particularly concerning the potential chilling effect on innovation and drug development

17:18: Kate provides her perspective on how march-in rights could influence private sector investment, potentially driving it outside the United States, and discusses the international adoption of similar legislative frameworks

19:54: Dr. Popovian shares some final thoughts

Contact Our Hosts

Dr. Robert Popovian, Chief Science Policy Officer at GHLF: rpopovian@ghlf.org

Ben Blanc, Associate Director, Digital Production and Engagement at GHLF: bblanc@ghlf.org

A podcast series produced by Ben Blanc.

We want to hear what you think. Send your comments, or a video or audio clip of yourself, to podcasts@ghlf.org

Listen to all episodes of Healthcare Matters on our website or on your favorite podcast channel.

In this episode, Dr. Robert Popovian and Ben Blanc are joined by Kate Hudson, Associate Vice President and Counsel for Government Relations and Public Policy at the Association of American Universities, to dissect the complex issue of march-in rights. They delve into how this regulation negatively influences the partnership between public research and private sector investment, which is crucial for supporting biopharmaceutical innovation from university labs to a patient’s bedside. The episode reveals march-in rights' potential risks and benefits, especially how the policy might impact innovation and patient access to future therapies.
Among the highlights in this episode:
02:25: Researchers found that 75% of all Food and Drug Administration-approved drugs between January 2008 and December 2017 were funded and researched by private companies, with only 19% of the approved drugs having origins in publicly supported research and development, and 6% originating in companies that were spun from publicly supported research programs
03:48: Kate shares her professional journey and current role at the Association of American Universities
06:06: Kate explains the concept of march-in rights under the Bayh-Dole Act, detailing its purpose, application, and implications for intellectual property generated from federally funded research
09:52: Dr. Popovian describes his involvement with University Pharmco and its mission to promote research commercialization, emphasizing the potential impact of march-in rights on such initiatives
12:19: Kate addresses why the debate around march-in rights is crucial from a patient's perspective, particularly concerning the potential chilling effect on innovation and drug development
17:18: Kate provides her perspective on how march-in rights could influence private sector investment, potentially driving it outside the United States, and discusses the international adoption of similar legislative frameworks
19:54: Dr. Popovian shares some final thoughts
Contact Our Hosts
Dr. Robert Popovian, Chief Science Policy Officer at GHLF: <a href="mailto:rpopovian@ghlf.org">rpopovian@ghlf.org</a>
Ben Blanc, Associate Director, Digital Production and Engagement at GHLF: <a href="mailto:bblanc@ghlf.org">bblanc@ghlf.org</a>
A podcast series produced by Ben Blanc.
We want to hear what you think. Send your comments, or a video or audio clip of yourself, to <a href="mailto:podcasts@ghlf.org">podcasts@ghlf.org</a>
Listen to all episodes of Healthcare Matters on our website or on your favorite podcast channel.

Welcome to Healthcare Matters! In this podcast, we talk about 'matters' in healthcare and why it matters to you! 

Our host Ben Blanc will speak with our talented Chief Science Officer Robert Popovian. And together, we will take on some pretty complex topics and distil them, so everyone can understand what is happening in the world of healthcare. 

The show is brought to you by the Global Healthy Living Foundation. 

www.ghlf.org

Welcome to Healthcare Matters! In this podcast, we talk about 'matters' in healthcare and why it matters to you! 
Our host Ben Blanc will speak with our talented Chief Science Officer Robert Popovian. And together, we will take on some pretty complex topics and distil them, so everyone can understand what is happening in the world of healthcare. 
The show is brought to you by the Global Healthy Living Foundation. 
www.ghlf.org

Healthcare Matters

A podcast that pulls back the curtain to help you make sense of complex healthcare economics and policy issues. Our goal is to help simplify the complexities in healthcare economics and policy issues for you.

The podcast is part of the Global Healthy Living Foundation Podcast Network and hosted by Dr. Robert Popovian, Chief Science Policy Officer at GHLF and Ben Blanc, Associate Director, Digital Production and Engagement at GHLF.

A podcast that pulls back the curtain to help you make sense of complex healthcare economics and policy issues. Our goal is to help simplify the complexities in healthcare economics and policy issues for you.
The podcast is part of the Global Healthy Living Foundation Podcast Network and hosted by Dr. Robert Popovian, Chief Science Policy Officer at GHLF and Ben Blanc, Associate Director, Digital Production and Engagement at GHLF.

S5, Ep 4- Balancing Act: March-In Rights and Medical Innovation

Join Dr. Robert Popovian and Ben Blanc for a special live episode from the World Vaccine Congress in Washington, DC, where they delve into the latest developments in vaccine policy and economic research. This episode spotlights the congress's role as a vital hub for collaboration and innovation in the vaccine industry.

Tune in to get an insider's view of the pivotal conversations shaping the future of vaccines.

Contact Our Hosts

Dr. Robert Popovian, Chief Science Policy Officer at GHLF: rpopovian@ghlf.org

Ben Blanc, Associate Director, Digital Production and Engagement at GHLF: bblanc@ghlf.org

A podcast series produced by Ben Blanc.

We want to hear what you think. Send your comments, or a video or audio clip of yourself, to podcasts@ghlf.org

Listen to all episodes of Healthcare Matters on our website or on your favorite podcast channel.

Join Dr. Robert Popovian and Ben Blanc for a special live episode from the World Vaccine Congress in Washington, DC, where they delve into the latest developments in vaccine policy and economic research. This episode spotlights the congress's role as a vital hub for collaboration and innovation in the vaccine industry.   Tune in to get an insider's view of the pivotal conversations shaping the future of vaccines.
Contact Our Hosts
Dr. Robert Popovian, Chief Science Policy Officer at GHLF: <a href="mailto:rpopovian@ghlf.org">rpopovian@ghlf.org</a>
Ben Blanc, Associate Director, Digital Production and Engagement at GHLF: <a href="mailto:bblanc@ghlf.org">bblanc@ghlf.org</a>
A podcast series produced by Ben Blanc.
We want to hear what you think. Send your comments, or a video or audio clip of yourself, to <a href="mailto:podcasts@ghlf.org">podcasts@ghlf.org</a>
Listen to all episodes of Healthcare Matters on our website or on your favorite podcast channel.

S5, Ep 3- Advancing Vaccine Policy: Live from the World Vaccine Congress

In this episode of Healthcare Matters, Dr. Robert Popovian and Ben Blanc take a deep dive into GHLF’s latest vaccine study with guests Dr. Wayne Winegarden, Senior Fellow in Business and Economics at the Pacific Research Institute (PRI) and Director of PRI's Center for Medical Economics and Innovation, and Esteban Rivera, Associate Director of Data Science and Economics at GHLF.

Together, they delve into the study, which underscores the pivotal role pharmacists play in vaccination efforts and the urgent need for regulatory reform. They discuss how pharmacies enhance vaccine access and affordability, especially in marginalized communities, the challenges posed by regulatory barriers, and suggest ways to reform these barriers to improve vaccination rates.

Tune in to explore how pharmacies can play a pivotal role in public health through streamlined vaccination processes.

Among the highlights in this episode:

03:04: Dr. Popovian, Chief Science Policy Officer at GHLF, discusses a statistic by the Center for Disease Control that nearly 60% of all flu vaccines were administered in pharmacies in the latest flu season, emphasizing the significant role pharmacists play in combating preventable diseases

03:53: Dr. Popovian explains the reasons behind GHLF’s new report on pharmacy-administered vaccinations, including previous findings on access in low-income communities and the preference for pharmacy vaccinations post-pandemic

06:18: Dr. Winegarden discusses the study's groundbreaking findings, particularly the complex and burdensome state regulations around vaccinations and their health and economic implications

09:10: Esteban Rivera elaborates on the cost-effectiveness of vaccinating patients at pharmacies compared to physician offices and highlights the equitable benefits of increased vaccine accessibility at pharmacies

10:24: Dr. Winegarden provides an example of the RSV vaccine to illustrate specific cost savings and health impacts of pharmacy versus physician office vaccinations

13:27: Esteban Rivera discusses the complexity of regulatory pathways for vaccination, emphasizing the need for simplification to reduce costs and improve accessibility

14:26: Dr. Popovian gives examples of states that have either streamlined or erected barriers for pharmacist immunization, particularly highlighting the negative impact on underserved communities in New York

16:16: Dr. Popovian advocates for state-level regulatory reform to grant pharmacists the same authority to immunize as physicians, stressing the importance of accessibility and convenience for patients 

18:24: Dr. Popovian shares some final thoughts

To access the full report, go to:https://ghlf.org/removing_barriers_to_pharmacy_vaccination/

Contact Our Hosts

Dr. Robert Popovian, Chief Science Policy Officer at GHLF: rpopovian@ghlf.org

Ben Blanc, Associate Director, Digital Production and Engagement at GHLF: bblanc@ghlf.org

A podcast series produced by Ben Blanc.

We want to hear what you think. Send your comments, or a video or audio clip of yourself, to podcasts@ghlf.org

Listen to all episodes of Healthcare Matters on our website or on your favorite podcast channel.

In this episode of Healthcare Matters, Dr. Robert Popovian and Ben Blanc take a deep dive into GHLF’s latest vaccine study with guests Dr. Wayne Winegarden, Senior Fellow in Business and Economics at the Pacific Research Institute (PRI) and Director of PRI's Center for Medical Economics and Innovation, and Esteban Rivera, Associate Director of Data Science and Economics at GHLF.
Together, they delve into the study, which underscores the pivotal role pharmacists play in vaccination efforts and the urgent need for regulatory reform. They discuss how pharmacies enhance vaccine access and affordability, especially in marginalized communities, the challenges posed by regulatory barriers, and suggest ways to reform these barriers to improve vaccination rates.
Tune in to explore how pharmacies can play a pivotal role in public health through streamlined vaccination processes.
Among the highlights in this episode:
03:04: Dr. Popovian, Chief Science Policy Officer at GHLF, discusses a statistic by the Center for Disease Control that nearly 60% of all flu vaccines were administered in pharmacies in the latest flu season, emphasizing the significant role pharmacists play in combating preventable diseases
03:53: Dr. Popovian explains the reasons behind GHLF’s new report on pharmacy-administered vaccinations, including previous findings on access in low-income communities and the preference for pharmacy vaccinations post-pandemic
06:18: Dr. Winegarden discusses the study's groundbreaking findings, particularly the complex and burdensome state regulations around vaccinations and their health and economic implications
09:10: Esteban Rivera elaborates on the cost-effectiveness of vaccinating patients at pharmacies compared to physician offices and highlights the equitable benefits of increased vaccine accessibility at pharmacies
10:24: Dr. Winegarden provides an example of the RSV vaccine to illustrate specific cost savings and health impacts of pharmacy versus physician office vaccinations
13:27: Esteban Rivera discusses the complexity of regulatory pathways for vaccination, emphasizing the need for simplification to reduce costs and improve accessibility
14:26: Dr. Popovian gives examples of states that have either streamlined or erected barriers for pharmacist immunization, particularly highlighting the negative impact on underserved communities in New York
16:16: Dr. Popovian advocates for state-level regulatory reform to grant pharmacists the same authority to immunize as physicians, stressing the importance of accessibility and convenience for patients 
18:24: Dr. Popovian shares some final thoughts
To access the full report, go to: <a href="https://ghlf.org/removing_barriers_to_pharmacy_vaccination/">https://ghlf.org/removing_barriers_to_pharmacy_vaccination/</a> 
Contact Our Hosts
Dr. Robert Popovian, Chief Science Policy Officer at GHLF: <a href="mailto:rpopovian@ghlf.org">rpopovian@ghlf.org</a>
Ben Blanc, Associate Director, Digital Production and Engagement at GHLF: <a href="mailto:bblanc@ghlf.org">bblanc@ghlf.org</a>
A podcast series produced by Ben Blanc.
We want to hear what you think. Send your comments, or a video or audio clip of yourself, to <a href="mailto:podcasts@ghlf.org">podcasts@ghlf.org</a>
Listen to all episodes of Healthcare Matters on our website or on your favorite podcast channel.

S5, Ep 2- Pharmacies and Public Health: Breaking Down Barriers to Pharmacy Vaccination

In this episode of Healthcare Matters, our hosts dive into the impact of pharmacy reimbursement on vaccination rates with guest Vibhu Tewary, researcher and

Project Director at IQVIA Institute for Human Data Science. Through discussing a recent study, they reveal how a modest increase in reimbursement can lead to higher flu vaccination rates among Medicaid-covered adults. The episode also touches on the role of pharmacies in public health, the need for policy reform to enhance vaccine accessibility, and the potential for future research to further improve public health outcomes.

Among the highlights in this episode:

01:50: Vibhu shares his background in public health and policy, emphasizing his commitment to impactful research for patient access and health care improvements 

04:21: Vibhu discusses the key findings from a 2023 paper that highlighted pharmacies as major vaccination sites, with over 90% of COVID-19 vaccinations for adults provided through pharmacies in 2021 and 2022

06:24: Dr. Popovian, Chief Science Policy Officer at GHLF, discusses the need to harmonize state laws to allow pharmacists to immunize more adults, addressing the disparities in pharmacy access and emphasizing the cost effectiveness of pharmacy-administered vaccinations

08:36: Dr. Popovian and Vibhu delve into the recent report co-authored by GHLF and IQVIA Institute for Human Data Science that establishes a direct link between increased pharmacy reimbursement rates and higher flu vaccination rates among Medicaid-covered adults 

You can find the full report athttps://www.iqvia.com/insights/the-iqvia-institute/reports-and-publications/reports/trends-in-adult-vaccination-in-the-us

10:24: Vibhu outlines the methodology and key findings of the study, demonstrating that a $13 increase in reimbursement could lead to a six-percentage point increase in vaccination rates, consistent across gender and race

13:50: Dr. Popovian suggests aligning Medicaid reimbursement rates for vaccinations with those of Medicare to address disparities in vaccination access among underserved populations

15:28: Dr. Popovian and Vibhu discuss potential areas for future research, including the role of pharmacists in vaccine distribution, patient awareness, and addressing health equity in adult vaccination

18:17: Dr. Popovian shares some final thoughts

Contact Our Hosts

Dr. Robert Popovian, Chief Science Policy Officer at GHLF: rpopovian@ghlf.org

Ben Blanc, Associate Director, Digital Production and Engagement at GHLF: bblanc@ghlf.org

A podcast series produced by Ben Blanc.

We want to hear what you think. Send your comments, or a video or audio clip of yourself, to podcasts@ghlf.org

Listen to all episodes of Healthcare Matters on our website or on your favorite podcast channel.

In this episode of Healthcare Matters, our hosts dive into the impact of pharmacy reimbursement on vaccination rates with guest Vibhu Tewary, researcher and
Project Director at IQVIA Institute for Human Data Science. Through discussing a recent study, they reveal how a modest increase in reimbursement can lead to higher flu vaccination rates among Medicaid-covered adults. The episode also touches on the role of pharmacies in public health, the need for policy reform to enhance vaccine accessibility, and the potential for future research to further improve public health outcomes.
Among the highlights in this episode:
01:50: Vibhu shares his background in public health and policy, emphasizing his commitment to impactful research for patient access and health care improvements 
04:21: Vibhu discusses the key findings from a 2023 paper that highlighted pharmacies as major vaccination sites, with over 90% of COVID-19 vaccinations for adults provided through pharmacies in 2021 and 2022
06:24: Dr. Popovian, Chief Science Policy Officer at GHLF, discusses the need to harmonize state laws to allow pharmacists to immunize more adults, addressing the disparities in pharmacy access and emphasizing the cost effectiveness of pharmacy-administered vaccinations
08:36: Dr. Popovian and Vibhu delve into the recent report co-authored by GHLF and IQVIA Institute for Human Data Science that establishes a direct link between increased pharmacy reimbursement rates and higher flu vaccination rates among Medicaid-covered adults 
You can find the full report at <a href="https://www.iqvia.com/insights/the-iqvia-institute/reports-and-publications/reports/trends-in-adult-vaccination-in-the-us">https://www.iqvia.com/insights/the-iqvia-institute/reports-and-publications/reports/trends-in-adult-vaccination-in-the-us</a>
10:24: Vibhu outlines the methodology and key findings of the study, demonstrating that a $13 increase in reimbursement could lead to a six-percentage point increase in vaccination rates, consistent across gender and race
13:50: Dr. Popovian suggests aligning Medicaid reimbursement rates for vaccinations with those of Medicare to address disparities in vaccination access among underserved populations
15:28: Dr. Popovian and Vibhu discuss potential areas for future research, including the role of pharmacists in vaccine distribution, patient awareness, and addressing health equity in adult vaccination
18:17: Dr. Popovian shares some final thoughts
Contact Our Hosts
Dr. Robert Popovian, Chief Science Policy Officer at GHLF: <a href="mailto:rpopovian@ghlf.org">rpopovian@ghlf.org</a>
Ben Blanc, Associate Director, Digital Production and Engagement at GHLF: <a href="mailto:bblanc@ghlf.org">bblanc@ghlf.org</a>
A podcast series produced by Ben Blanc.
We want to hear what you think. Send your comments, or a video or audio clip of yourself, to <a href="mailto:podcasts@ghlf.org">podcasts@ghlf.org</a>
Listen to all episodes of Healthcare Matters on our website or on your favorite podcast channel.

S5, Ep 4- Balancing Act: March-In Rights and Medical Innovation

In 1 playlist(s)

Healthcare Matters

Social links

Follow podcast

Recent clips